title: Conclusions regarding the efficacy of treatments for neuroleptic malignant syndrome should be tempered given poor quality data, regardless of the analysis conducted.
authors.forename: Darren M
authors.initials: DM
authors.lastname: Roberts
authors.forename: Jason A
authors.initials: JA
authors.lastname: Roberts
mesh_terms: D003620:Dantrolene / Q000627:therapeutic use; D006801:Humans; D009125:Muscle Relaxants, Central / Q000627:therapeutic use; D009459:Neuroleptic Malignant Syndrome / Q000628:therapy*; D012107:Research Design; D016896:Treatment Outcome
chemical_list: D009125:Muscle Relaxants, Central; D003620:Dantrolene